These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6243515)

  • 1. In vitro killing of tumor cells by soluble products of activated guinea pig peritoneal macrophages.
    Sharma SD; Piessens WF; Middlebrook G
    Cell Immunol; 1980 Feb; 49(2):379-83. PubMed ID: 6243515
    [No Abstract]   [Full Text] [Related]  

  • 2. Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG).
    Zwilling BS; Leonard EJ; Bast RC; Zbar B
    J Natl Cancer Inst; 1974 Aug; 53(2):541-6. PubMed ID: 4367248
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
    Fidler IJ; Kataoka T; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells.
    Bucana C; Hoyer LC; Hobbs B; Breesman S; McDaniel M; Hanna MG
    Cancer Res; 1976 Dec; 36(12):4444-58. PubMed ID: 187323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. III. Inhibition by cytochalasins, colchicine, and vinblastine.
    Sharma SD; Piessens WF
    Cell Immunol; 1978 Jul; 38(2):276-85. PubMed ID: 209902
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple in vitro mechanisms of tumor cytotoxicity demonstrated in the line-1 guinea pig hepatoma model.
    Osteen RT; Piessens WF; David JR; Churchill WH
    J Natl Cancer Inst; 1975 Oct; 55(4):873-8. PubMed ID: 52720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. II. Inhibition by inhibitors of protein synthesis.
    Sharma SD; Piessens WF
    Cell Immunol; 1978 Jul; 38(2):264-75. PubMed ID: 209901
    [No Abstract]   [Full Text] [Related]  

  • 8. Brief communication: antigenic relationship between Mycobacterium bovis (BCG) and a guinea pig hepatoma.
    Borsos T; Rapp HJ
    J Natl Cancer Inst; 1973 Sep; 51(3):1085-6. PubMed ID: 4355214
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.
    Piessens WF; Churchill WH; David
    J Immunol; 1975 Jan; 114(1 Pt 2):293-9. PubMed ID: 163856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated macrophage-mediated cytotoxicity: use of the in vitro cytotoxicity assay for study of bioenergetic and biochemical changes that develop in tumor target cells.
    Hibbs JB; Taintor RR
    Methods Enzymol; 1986; 132():508-20. PubMed ID: 3821524
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    Bucana C; Hanna MG
    J Natl Cancer Inst; 1974 Nov; 53(5):1313-23. PubMed ID: 4139279
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of concanavalin A on the cytotoxicity of rat peritoneal macrophages.
    Toh K; Sato N; Kikuchi K
    J Reticuloendothel Soc; 1979 Jan; 25(1):17-28. PubMed ID: 430468
    [No Abstract]   [Full Text] [Related]  

  • 13. Partial characterization of anti-tumor effector macrophages in the peritoneal cavities of concomitantly immune mice and mice injected with macrophage-stimulating agents.
    Hopper KE; Harrison J; Nelson DS
    J Reticuloendothel Soc; 1979 Sep; 26(3):259-71. PubMed ID: 115998
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor cell killing by macrophages activated in vitro with lymphocyte mediators. 5. Role of proteases, inhibitors, and substrates.
    Piessens WF; Sharma SD
    Cell Immunol; 1980 Dec; 56(2):286-91. PubMed ID: 6781762
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential stimulation of murine lymphoma growth in vitro by normal and BCG-activated macrophages.
    Nathan CF; Terry WD
    J Exp Med; 1975 Oct; 142(4):887-902. PubMed ID: 170358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculature.
    Galli SJ; Bast RC; Bast BS; Isomura T; Zbar B; Rapp HJ; Dvorak HF
    J Immunol; 1982 Aug; 129(2):890-9. PubMed ID: 6282973
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction--heterogeneity of the cellular immune response.
    Dvorak HF
    Adv Exp Med Biol; 1979; 114():369-74. PubMed ID: 223416
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased binding of tumor cells by macrophages activated in vitro with lymphocyte mediators.
    Piessens WF
    Cell Immunol; 1978 Feb; 35(2):303-17. PubMed ID: 202405
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets.
    Zbar B; Rapp HJ; Ribi EE
    J Natl Cancer Inst; 1972 Mar; 48(3):831-5. PubMed ID: 4333775
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural cytotoxic cells against solid tumors in mice. II. Some characteristics of the effector cells.
    Paige CJ; Figarella EF; Cuttito MJ; Cahan A; Stutman O
    J Immunol; 1978 Nov; 121(5):1827-35. PubMed ID: 361891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.